Kaken Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 59.82% vs 3.36% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 3,014.02% vs -84.55% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30,154.00",
          "val2": "18,867.00",
          "chgp": "59.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11,903.00",
          "val2": "650.00",
          "chgp": "1,731.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.00",
          "val2": "10.00",
          "chgp": "40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "1.00",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,439.00",
          "val2": "271.00",
          "chgp": "3,014.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "361.60%",
          "val2": "0.70%",
          "chgp": "36.09%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -18.25% vs 30.52% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -84.63% vs 73.77% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "76,871.00",
          "val2": "94,035.00",
          "chgp": "-18.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,426.00",
          "val2": "23,590.00",
          "chgp": "-89.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "45.00",
          "val2": "28.00",
          "chgp": "60.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-724.00",
          "val2": "-2,025.00",
          "chgp": "64.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,144.00",
          "val2": "13,945.00",
          "chgp": "-84.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11.70%",
          "val2": "223.70%",
          "chgp": "-23.54%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY

Jun'26

Jun'25

Change(%)

Net Sales

30,154.00

18,867.00

59.82%

Operating Profit (PBDIT) excl Other Income

11,903.00

650.00

1,731.23%

Interest

14.00

10.00

40.00%

Exceptional Items

-2.00

1.00

-300.00%

Consolidate Net Profit

8,439.00

271.00

3,014.02%

Operating Profit Margin (Excl OI)

361.60%

0.70%

36.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2026 is 59.82% vs 3.36% in Jun 2025

Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is 3,014.02% vs -84.55% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

76,871.00

94,035.00

-18.25%

Operating Profit (PBDIT) excl Other Income

2,426.00

23,590.00

-89.72%

Interest

45.00

28.00

60.71%

Exceptional Items

-724.00

-2,025.00

64.25%

Consolidate Net Profit

2,144.00

13,945.00

-84.63%

Operating Profit Margin (Excl OI)

-11.70%

223.70%

-23.54%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -18.25% vs 30.52% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -84.63% vs 73.77% in Mar 2025

All Annual Results